What changed in this filing

/stocks — the workspaceLOADING

Item 2. Management’s Discussion and Analysis

2023-10-25 compared with 2023-06-29 · 211 added, 122 removed, 314 unchanged (51% of the section changed)

114 unchanged sentences

with a developer for this planned concept development.

We previously

owned We Three , LLC dba Affordable Housing Initiative, or AHI, which was acquired on May

15, 2014 and sold on October 31, 2022.

AHI leased and sold mobile homes and also provided a “lease to own” option.

During the three months March 31, 2023 and 2022,

we had four reportable operating segments as determined by management using the “management approach” as defined by the authoritative

guidance on Disclosures about Segments of an Enterprise and Related Information :

We previously owned We Three, LLC dba Affordable

Housing Initiative, or AHI, which was acquired on May 15, 2014 and sold on October 31, 2022.

AHI leased and sold mobile homes and also

provided a “lease to own” option.

During the three months ended June 30, 2023 and

2022, we had three reportable operating segments as determined by management using the “management approach” as defined by

the authoritative guidance on Disclosures about Segments of an Enterprise and Related Information :

Financial Services (Platinum Tax)

25 unchanged sentences

We had no net liabilities of discontinued operations

at March 31, 2023 and December 31, 2022.

We had $0 and $19,215 of loss from discontinued operations for the three months ended March 31,

at June 30, 2023 and December 31, 2022.

We had $0 and $35,542 of loss from discontinued operations for the six months ended June 30, 2023

and 2022, respectively.

Results of Operations

Comparison of Three Months Ended March 31,

Comparison of Three Months Ended June 30,

2023 and 2022

The following table sets forth key components

of our results of operations during the three months ended March 31, 2023 and 2022, both in dollars and as a percentage of our revenue.

March 31, 2023

March 31, 2022

of our results of operations during the three months ended June 30, 2023 and 2022, both in dollars and as a percentage of our revenue.

June 30, 2023

June 30, 2022

Financial services

9 unchanged sentences

Other income (expense)

Gain on forgiveness of debt

Penalties and fees

Interest expense and finance charge

Conversion cost penalty and reimbursement

Penalties and fees

Amortization of debt discounts

Total other income (expense)

Net loss before discontinued operations

Net income (loss) before discontinued operations

Loss from discontinued operations

$ (1,562,454 )

Deemed dividends on preferred stock

Net loss attributable to common shareholders

Our total revenue decreased

by $36,352, or 1.25%, to $2,860,798 for the three months ended March 31, 2023 from $2,897,150 for the three months ended March 31, 2022.

Such decrease was primarily due to decreases in revenue from the financial services, offset by an increase in revenue from the healthcare

Net income (loss)

Our total revenue increased

by $391,578, or 12.67%, to $3,482,810 for the three months ended June 30, 2023 from $3,091,232 for the three months ended June 30, 2022.

Such increase was primarily due to increases in revenue from the healthcare segment.

The financial services segment generates revenue

1 unchanged sentence

Revenue from the financial services segment decreased

by $310,444, or 66.78%, to $154,399 for the three months ended March 31, 2023 from $464,843 for the three months ended March 31, 2022.

Such decrease was primarily due to the loss of leads from the discontinued service with Optima Tax Relief, which affected the significant

revenue reduction in the tax resolution business.

by $353,710, or 74.94%, to $118,304 for the three months ended June 30, 2023 from $472,014 for the three months June 30, 2022.

Such decrease

was primarily due to the loss of sales leads from the discontinued service with Optima Tax Relief, which affected the significant revenue

reduction in the tax resolution business.

The healthcare segment generates revenue through

1 unchanged sentence

Revenue from the healthcare services segment increased by $745,288, or 28.45%, to $3,364,506

for the three months ended March 31, 2023 from $2,432,307 for the three months ended March 31, 2022.

Such increase was primarily due to

increased Personal Injury Protection (PIP) services.

for the three months ended June 30, 2023 from $2,619,218 for the three months June 30, 2022.

Such increase was primarily due to increased

patients and Personal Injury Protection (PIP) services.

Cost of sales .

Our total cost of

sales decreased by $133,104, or 11.92%, to $983,124 for the three months ended March 31, 2023 from $1,116,228 for the three months ended

March 31, 2022.

Such decrease was primarily due a decrease from the financial service segment, offset by an increase from the healthcare

As a percentage of revenue, our total cost of sales was 34.37% and 38.53% for the three months ended March 31, 2023 and 2022,

respectively.

sales increased by $6,368 or 0.58%, to $2,379,824 for the three months ended June 30, 2023 from $1,994,614 for the three months June 30,

Such increase was primarily due a decrease from the financial service segment, offset by an increase from the healthcare segment.

As a percentage of revenue, our total cost of sales was 31.67% and 35.48% for the three months ended June 30, 2023 and 2022, respectively.

Cost of sales for the financial services segment

1 unchanged sentence

Cost of sales for the financial services segment decreased by $91,479, or 81.12%,

87.37%, to $26,829 for the three months ended March 31, 2023 from $212,446 for the three months ended March 31, 2022.

As a percentage

of financial services revenue, cost of sales was 17.38% and 45.70% for the three months ended March 31, 2023 and 2022, respectively.

decrease was generally in line with the decrease in revenue from this segment.

to $21,297 for the three months ended June 30, 2023 from $112,776 for the three months June 30, 2022.

As a percentage of financial services

revenue, cost of sales was 0.61% and 3.65% for the three months ended June 30, 2023 and 2022, respectively.

Cost of sales for the healthcare segment consists

1 unchanged sentence

Cost of sales from the healthcare services

segment increased by $52,513, or 5.81%, to $956,295 for the three months ended March 31, 2023 from $903,782 for the three months ended

March 31, 2022.

As a percentage of healthcare revenue, cost of sales was 35.33% and 37.16% for the three months ended March 31, 2023 and

segment increased by $97,847, or 9.95%, to $1,081,689 for the three months ended June 30, 2023 from $983,842 for the three months June

As a percentage of healthcare revenue, cost of sales was 31.06% and 31.83% for the three months ended June 30, 2023 and 2022,

respectively.

This slight increase was primarily due to increased labor costs.

This increase was due to increased surgical center fees and professional fees.

Gross profit .

As a result of the

foregoing, our total gross profit increased by $96,752, or 5.43%, to $1,877,674 for the three months ended March 31, 2023 from $1,780,922

for three months ended March 31, 2022.

Our total gross margin (percent of revenue) was 65.63% and 61.47% for three months ended March

foregoing, our total gross profit increased by $385,210, or 19.31%, to $2,379,824 for the three months ended June 30, 2023 from $31,994,614

for three months ended June 30, 2022.

Our total gross margin (percent of revenue) was 68.33% and 64.52% for three months ended June 30,

2023 and 2022, respectively.

Gross profit for the financial services segment

decreased by $124,827, or 49.46%, to $127,570 for the three months ended March 31, 2023 from $252,397 for the three months ended March

Gross margin (percent of revenue) for the financial services segment was 82.62% and 54.30% for the three months ended March

31, 2023 and 2022, respectively.

decreased by $262,231, or 73.00%, to $97,007 for the three months ended June 30, 2023 from $359,238 for the three months June 30, 2022.

Gross margin (percent of revenue) for the financial services segment was 82.00% and 76.11% for the three months ended June 30, 2023 and

2022, respectively.

Gross profit for the healthcare services segment

increased by $221,579, or 14.5%, to $1,750,104 for the three months ended March 31, 2023 from $1,528,525 for the three months ended March

Gross margin (percent of revenue) for the healthcare segment was 64.67% and 62.84% for the for the three months ended March

increased by $647,441, or 39.59%, to $2,282,817 for the three months ended June 30, 2023 from $1,635,376 for the three months ended June

Gross margin (percent of revenue) for the healthcare segment was 67.85% and 62.44% for the three months ended June 30, 2023

and 2022, respectively.

The increased gross margin was due to the increased number of patients and provided medical services without increased

The healthcare segment still had available capacity to cover the increased patients and services.

Depreciation expense .

Our depreciation

expense was $4,635, or 0.16% of revenue, for the three months ended March 31, 2023, as compared to $5,783, or 0.20% of revenue, for the

three months ended March 31, 2022.

expense was $3,365, or 0.10% of revenue, for the three months June 30, 2023, as compared to $5,783, or 0.19% of revenue, for the three

months June 30, 2022.

Selling, general and administrative expenses .

3 unchanged sentences

Our selling, general and administrative expenses

increased by $105,822, or 10.04%, to $1,159,478 for the three months ended March 31, 2023 from $1,053,656 for the three months ended March

As a percentage of revenue, our selling, general and administrative expenses were 40.69% and 36.37% for the three months ended

March 31, 2023 and 2022, respectively.

Such increase was primarily due to the bad debt expense for allowances for doubtful accounts relating

decreased by $195,924, or 22.62%, to $670,289 for the three months ended June 30, 2023 from $866,213 for the three months ended June 30,

As a percentage of revenue, our selling, general and administrative expenses were 19.25% and 28.02% for the three months ended June

30, 2023 and 2022, respectively.

Such decrease was primarily due to terminated employees in the financial services segment due to the

decreased revenue and the bad debt expense for allowances for doubtful accounts relating to our healthcare services business.

Total other income (expense) .

had $890,092 in total other expense, net, for the three months ended June 30, 2023, as compared to other expense, net, of $1,147,509 for

the three months ended June 30, 2022.

Other expenses, net, for the three months ended June 30, 2023 consisted of interest expense and

finance charges of $844,459, amortization of debt discounts of $30,633, and financing penalties and fees of $15,000.

Other expense, net,

for the three months ended June 30, 2022 consisted of interest expense and finance charges of $1,035,811, and amortization of debt discounts

of $111,706, offset by other income of $8.

Discontinued operations .

the three months ended June 30, 2023 and 2022, we recorded a loss from discontinued operations of $0 and $36,935, respectively.

Net income (loss) .

As a result of

the cumulative effect of the factors described above, our net income was $816,078 for the three months ended June 30, 2023, as compared

to net loss of $61,826 for the three months ended June 30, 2022, an increase of $754,252, or 1219.96%.

Comparison of Six Months Ended June 30,

2023 and 2022

The following table sets forth key components

of our results of operations during the six months ended June 30, 2023 and 2022, both in dollars and as a percentage of our revenue.

June 30, 2023

June 30, 2022

Financial services

Total revenue

Cost of sales

Financial services

Total cost of sales

Operating expenses

Depreciation expense

Selling, general and administrative

Total operating expenses

Income from operations

Other income (expense)

Gain on forgiveness of debt

Interest expense & finance charge

Conversion cost penalty and reimbursement

Penalties and fees

Amortization of debt discounts

Total other income (expense)

Net income (loss) before discontinued operations

Income (loss) from discontinued operations

$ (1,624,280 )

Our total revenue increased

by $355,226, or 5.93%, to $6,343,608 for the six months ended June 30, 2023 from $5,988,382 for the six months ended June 30, 2022.

increase was primarily due to increases in revenue from the healthcare segment.

Revenue from the financial services segment decreased

by $664,154, or 70.89%, to $272,703 for the six months ended June 30, 2023 from $936,857 for the six months ended June 30, 2022.

decrease was primarily due to the loss of sales leads from the discontinued service with Optima Tax Relief, which affected the significant

revenue reduction in the tax resolution business.

Revenue from the healthcare services segment increased

by $1,019,380, or 20.18%, to $6,070,905 for the six months ended June 30, 2023 from $5,051,525 for the six months ended June 30, 2022.

Such increase was primarily due to increased Personal Injury Protection (PIP) services.

Cost of sales .

Our total cost of

sales decreased by $126,737 or 5.73%, to $2,086,109 for the six months ended June 30, 2023 from $2,212,846 for the six months ended June

Such decrease was primarily due a decrease from the financial service segment, offset by an increase from the healthcare segment.

As a percentage of revenue, our total cost of sales was 32.89% and 36.95% for the six months ended June 30, 2023 and 2022, respectively.

Cost of sales for the financial services segment

decreased by $277,096, or 85.20%, to $48,126 for the six months ended June 30, 2023 from $325,222 for the six months ended June 30, 2022.

As a percentage of financial services revenue, cost of sales was 0.76% and 5.43% for the six months ended June 30, 2023 and 2022, respectively.

Cost of sales from the healthcare services segment

increased by $150,359, or 7.97%, to $2,037,983 for the six months ended June 30, 2023 from $1,887,624 for the six months ended June 30,

As a percentage of healthcare revenue, cost of sales was 32.13% and 31.52% for the six months ended June 30, 2023 and 2022, respectively.

This increase was generally in line with the increase in revenue from this segment.

Gross profit .

As a result of the

foregoing, our total gross profit increased by $481,963, or 12.77%, to $4,257,499 for the six months ended June 30, 2023 from $3,775,536

for six months ended June 30, 2022.

Our total gross margin (percent of revenue) was 67.11% and 63.05% for six months ended June 30, 2023

and 2022, respectively.

Gross profit for the financial services segment

decreased by $387,058, or 63.28%, to $224,577 for the six months ended June 30, 2023 from $611,635 for the six months ended June 30, 2022.

Gross margin (percent of revenue) for the financial services segment was 82.35% and 65.29% for the six months ended June 30, 2023 and

2022, respectively.

Gross profit for the healthcare services segment

increased by $869,021, or 27.47%, to $4,032,922 for the six months ended June 30, 2023 from $3,163,901 for the six months ended June 30,

Gross margin (percent of revenue) for the healthcare segment was 66.43% and 62.63% for the six months ended June 30, 2023 and 2022,

respectively.

The increased gross margin was due to the increased number of patients and provided medical services without increased overhead.

The healthcare segment still had available capacity to cover the increased patients and services.

Depreciation expense .

Our depreciation

expense was $8,000, or 0.13% of revenue, for the six months ended June 30, 2023, as compared to $11,566, or 0.19% of revenue, for the

six months ended June 30, 2022.

Selling, general and administrative expenses .

Our selling, general and administrative expenses decreased by $110,709, or 5.71%, to $1,829,768 for the six months ended June 30, 2023

from $1,940,477 for the six months ended June 30, 2022.

As a percentage of revenue, our selling, general and administrative expenses were

28.97% and 32.40% for the six months ended June 30, 2023 and 2022, respectively.

Such decrease was primarily due to terminated employees

in the financial services segment due to the decreased revenue and the bad debt expense for allowances for doubtful accounts relating

to our healthcare services business.

Total other income (expense) .

had $729,552 in total other expense, net, for the three months ended March 31, 2023, as compared to other expense, net, of $2,264,722

for the three months ended March 31, 2022.

Other expense, net, for the three months ended March 31, 2023 consisted of interest expense

and finance charges of $695,164, amortization of debt discounts of $17,983, financing penalties and fees of $15,000 and conversion cost

penalty and reimbursement related to convertible note of $2,000, offset by other income of $595.

Other expense, net, for the three months

ended March 31, 2022 consisted of interest expense and finance charges of $2,220,176 and amortization of debt discounts of $44,546.

had $1,619,644 in total other expense, net, for the six months ended June 30, 2023, as compared to other expense, net, of $3,412,231 for

the six months ended June 30, 2022.

Other expense, net, for the six months ended June 30, 2023 consisted of interest expense and finance

charges of $1,539,623, amortization of debt discounts of $48,616, financing penalties and fees of $30,000 and conversion cost penalty

and reimbursement related to convertible note of $2,000, offset by other income of $595.

Other expenses, net, for the six months ended

June 30, 2022 consisted of interest expense and finance charges of $3,255,987 and amortization of debt discounts of $156,252, offset by

other income of $8.

Discontinued operations .

the three months ended March 31, 2023 and 2022, we recorded a loss from discontinued operations of $0 and $19,215, respectively.

As a result of the cumulative

effect of the factors described above, our net loss was $15,991 for the three months ended March 31, 2023, as compared to net loss of

$1,562,454 for the three months ended March 31, 2022, an increase of $1,546,463, or 98.98%.

the six months ended June 30, 2023 and 2022, we recorded a loss from discontinued operations of $0 and $35,542, respectively.

Net income (loss) .

As a result of

the cumulative effect of the factors described above, our net income was $800,087 for the six months ended June 30, 2023, as compared

to net loss of $1,624,280 for the six months ended June 30, 2022, an increase of $2,424,367, or 149.26%.

Liquidity and Capital Resources

As of March 31, 2023, we had $350,329 in cash.

As of June 30, 2023, we had $411,209 in cash.

To date, we have financed our operations primarily through revenue generated from operations, sales of securities, advances from stockholders

16 unchanged sentences

We intend to raise capital for additional acquisitions

primarily through equity and debt financings.

primarily through equity and debt financing.

The sale of additional equity securities could result in dilution to our stockholders.

5 unchanged sentences

The following table provides detailed information

about our net cash flow for the three months ended March 31, 2023 and 2022.

Three Months Ended March 31,

about our net cash flow for the six months ended June 30, 2023 and 2022.

Six Months Ended June 30,

Net cash used in operating activities from continuing operations

5 unchanged sentences

Our net cash used in operating activities from

continuing operations was $189,507 for the three months ended March 31, 2023, as compared to $376,453 for the three months ended March

For the three months ended March 31, 2023, our net loss of $15,991, an increase in bad debt expense of $270,000, fair value

settled upon conversion of $123,566, accounts payable and accrued expenses of $241,945, an increase in accrued officer’s compensation

of $154,000 and an increase in accrued interest of $123,074, offset by an in accounts receivable of $1,111,636, were the primary drivers

for the cash used in operations.

For the three months ended March 31, 2022, our net loss of $1,562,454 and a increase in accounts receivable

of $343,840, offset by increased accounts payable and accrued expense of $569,508 and an increase in accrued officers’ compensation

of $120,000, were the primary drivers for the cash used in operations.

We had no investing activities for the three months

ended March 31, 2023 and 2022.

continuing operations was $304,173 for the six months ended June 30, 2023, as compared to $473,175 for the six months ended June 30, 2022.

For the six months ended June 30, 2023, our net income of $800,087, an increase in accounts payable and accrued expenses of $693,788,

an increase in accrued officer’s compensation of $334,000, an increase in accrued interest of $248,137, an increase in bad debt

expense of $270,000 and fair value settled upon conversion of $123,566, offset by a decrease in accounts receivable of $2,858,749, were

the primary drivers for the cash used in operations.

For the six months ended June 30, 2022, our net loss of $1,624,280 and a decrease

in accounts receivable of $192,425, offset by increased accounts payable and accrued expense of $699,107 an increase in accrued interest

of $252,634 and an increase in accrued officers’ compensation of $240,000, were the primary drivers for the cash used in operations.

We had no investing activities for the six months

ended June 30, 2023 and 2022.

Our net cash provided by financing activities

was $313,034 for the three months ended March 31, 2023, as compared to $300,307 for the three months ended March 31, 2023.

was $488,580 for the six months ended June 30, 2023, as compared to $450,708 for the six months ended June 30, 2023.

Net cash provided

by operating activities for the three months ended March 31, 2023 consisted of proceeds from convertible notes payable of $240,000, proceeds

by financing activities for the six months ended June 30, 2023 consisted of proceeds from convertible notes payable of $355,500, proceeds

from related party notes payable of $124,696 and proceeds from line of credit of $43,880, offset by repayments of line of credit of $30,160

payment of related party notes payable of $835 and payment of the SBA loan described below of $750.

Net cash provided by financing activities

for the three months ended March 31, 2022 consisted of proceeds from convertible notes payable of $405,730 and proceeds from related party

notes payable of $4,803, offset by preferred stock dividends of $102,746, repayment of convertible notes payable of $5,908, payment of

related party notes payable of $816 and payment of the SBA loan described below of $756.

and payment of related party notes payable of $5,336.

Net cash provided by financing activities for the six months ended June 30, 2022

consisted of proceeds from convertible notes payable of $555,730 and proceeds from related party notes payable of $7,948, offset by preferred

stock dividends of $100,477, repayment of convertible notes payable of $5,908, payment of related party notes payable of $5,065 and payment

of the SBA loan described below of $1,520.

Convertible Notes

As of March 31, 2023, we had convertible debt

outstanding net of amortized debt discount of $3,717,936.

During the three months ended March 31, 2023, we received net proceeds of $240,000

from convertible notes and converted $58,800 of convertible debt, $5,873 in accrued interest and $1,390 in penalties and fees into 118,682,378

shares of common stock.

The Company recognized $123,566 of interest expense and additional paid-in capital to adjust fair value for the

debt settlement during the three months ended March 31, 2023.

For the three months ended March 31, 2023 and 2022, we recorded amortization

of debt discounts of $17,983 and $44,546, respectively.

As of June 30, 2023, we had convertible debt outstanding

net of amortized debt discount of $3,868,068.

During the six months ended June 30, 2023, we received net proceeds of $355,500 from convertible

notes and converted $58,800 of convertible debt, $5,873 in accrued interest and $2,000 in penalties and fees into 118,682,378 shares of

common stock.

The Company recognized $123,566 of interest expense and additional paid-in capital to adjust fair value for the debt settlement

during the six months ended June 30, 2023.

For the six months ended June 30, 2023, we recorded amortization of debt discounts of $48,616.

The following is a schedule of convertible notes

payable outstanding as of March 31, 2023:

Unamortized Debt

payable outstanding as of June 30, 2023:

On September 12, 2016, we issued

40 unchanged sentences

interest at a default interest rate of 22% per annum.

Notes 40-1, 40-2, 40-3, 40-4, 40-5 and 40-6 .

On September 22, 2022, we issued a convertible promissory note in the principal amount of $2,600,000 in exchange for total of $4,791,099

of defaulted promissory notes balances (Note 40-1).

On November 4, 2022, we executed a second tranche under this note in the principal

amount of $68,667, less an original issue discount and fee of $18,667 (Note 40-2).

On November 28, 2022, we executed the third tranche

under this note in the principal amount of $68,667, less an original issue discount and fee of $18,667 (Note 40-3).

On November 28, 2022,

we executed a fourth tranche under this note in the principal amount of $68,667, less an original issue discount and fee of $18,667 (Note

On January 24, 2023, we executed a fifth tranche under this note in the principal amount of $88,667, less an original issue discount

and fee of $25,166 (Note 40-5).

On March 21, 2023, we executed a sixth tranche under this note in the principal amount of $136,666, less

Note 40-1 through 40-8 .

On September 22,

2022, we issued a convertible promissory note in the principal amount of $2,600,000 in exchange for total of $4,791,099 of defaulted promissory

notes balances (Note 40-1).

On November 4, 2022, we executed a second tranche under this note in the principal amount of $68,667, less

an original issue discount and fee of $18,667 (Note 40-2).

All of the Note 40 tranches mature in one year from the note issuance date

and accrue interest at a rate of 10% per annum.

On November 28, 2022, we executed the third tranche under this note in the

principal amount of $68,667, less an original issue discount and fee of $18,667 (Note 40-3).

On November 28, 2022, we executed a fourth

tranche under this note in the principal amount of $68,667, less an original issue discount and fee of $18,667 (Note 40-4).

24, 2023, we executed a fifth tranche under this note in the principal amount of $90,166, less an original issue discount and fee of $25,166

On March 21, 2023, we executed a sixth tranche under this note in the principal amount of $136,666, less an original issue

discount and fee of $39,166 (Note 40-6).

On June 5, 2023, we executed a seventh tranche under this note in the principal amount of $136,667,

less original issue discount and fee of $39,167 (Note 40-7).

On June 13, 2023, we executed an eighth tranche under this note in the principal

amount of $21,167, less original issue discount and fee of $5,167 (Note 40-8).

All of the Note 40 tranches mature in one year from the

note issuance date and accrue interest at a rate of 10% per annum.

Line of Credit

2 unchanged sentences

The loan accrues

interest at 11.20% as of March 31, 2023.

As of March 31, 2023, the outstanding balance was $20,619.

interest at 11.70% as of June 30, 2023.

As of June 30, 2023, the outstanding balance was $8,749.

Small Business Administration Loan

1 unchanged sentence

Small Business Administration, or SBA, in the principal amount of $150,000 with an interest rate of 3.75% and a maturity date of June

We reclassified $5,723 of accrued interest to the principal amount for the three months ended March 31, 2023.

We reclassified $5,723 of accrued interest to the principal amount for the six months ended June 30, 2023.

The principal balance

and accrued interest at March 31, 2023 was $149,633 and $0, respectively.

and accrued interest at June 30, 2023 was $149,580 and $0, respectively.

On March 12, 2009, we issued a debenture in the

2 unchanged sentences

The balance of the debenture

was $10,989 at March 31, 2023 and the accrued interest was $6,554.

was $10,989 at June 30, 2023 and the accrued interest was $6,882.

We assigned all of our receivables from consumer activations of our

3 unchanged sentences

manager of Platinum Tax loaned funds to Platinum Tax to cover short term operating needs.

The amount owed as of March 31, 2023 was $90,189.

The amount owed as of June 30, 2023 was $156,384.

In connection with the acquisition of Edge View

2 unchanged sentences

do not bear interest.

The balance of these amounts are $4,979 as of March 31, 2023.

The balance of these amounts are $4,979 as of June 30, 2023.

We have obtained short-term advances from the

Chairman of the Board that are non-interest bearing and due on demand.

As of March 31, 2023, we owed the Chairman $123,192.

As of June 30, 2023, we owed the Chairman $123,192.

Critical Accounting Policies

13 unchanged sentences

Off Balance Sheet Arrangements

As of March 31, 2023, we had no off-balance sheet

As of June 30, 2023, we had no off-balance sheet

arrangements.

2 unchanged sentences

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 2. Management’s Discussion and Analysis